rs2293275

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000233.4(LHCGR):​c.935A>G​(p.Asn312Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.582 in 1,565,618 control chromosomes in the GnomAD database, including 273,076 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 22631 hom., cov: 33)
Exomes 𝑓: 0.59 ( 250445 hom. )

Consequence

LHCGR
NM_000233.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.19
Variant links:
Genes affected
LHCGR (HGNC:6585): (luteinizing hormone/choriogonadotropin receptor) This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]
GTF2A1L (HGNC:30727): (general transcription factor IIA subunit 1 like) The assembly and stability of the RNA polymerase II transcription pre-initiation complex on a eukaryotic core promoter involve the effects of transcription factor IIA (TFIIA) on the interaction between TATA-binding protein (TBP) and DNA. This gene encodes a germ cell-specific counterpart of the large (alpha/beta) subunit of general transcription factor TFIIA that is able to stabilize the binding of TBP to DNA and may be uniquely important to testis biology. Alternative splicing for this locus has been observed and two variants, encoding distinct isoforms, have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (SALF), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 2-48694236-T-C is Benign according to our data. Variant chr2-48694236-T-C is described in ClinVar as [Benign]. Clinvar id is 255609.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-48694236-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.91 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LHCGRNM_000233.4 linkc.935A>G p.Asn312Ser missense_variant Exon 10 of 11 ENST00000294954.12 NP_000224.2 P22888-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LHCGRENST00000294954.12 linkc.935A>G p.Asn312Ser missense_variant Exon 10 of 11 1 NM_000233.4 ENSP00000294954.6 P22888-1
ENSG00000279956ENST00000602369.3 linkn.*208A>G non_coding_transcript_exon_variant Exon 9 of 13 5 ENSP00000473498.1 R4GN57
ENSG00000279956ENST00000602369.3 linkn.*208A>G 3_prime_UTR_variant Exon 9 of 13 5 ENSP00000473498.1 R4GN57

Frequencies

GnomAD3 genomes
AF:
0.524
AC:
79577
AN:
151958
Hom.:
22629
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.298
Gnomad AMI
AF:
0.491
Gnomad AMR
AF:
0.635
Gnomad ASJ
AF:
0.644
Gnomad EAS
AF:
0.932
Gnomad SAS
AF:
0.619
Gnomad FIN
AF:
0.580
Gnomad MID
AF:
0.649
Gnomad NFE
AF:
0.581
Gnomad OTH
AF:
0.568
GnomAD3 exomes
AF:
0.613
AC:
143913
AN:
234642
Hom.:
46054
AF XY:
0.613
AC XY:
77420
AN XY:
126368
show subpopulations
Gnomad AFR exome
AF:
0.287
Gnomad AMR exome
AF:
0.707
Gnomad ASJ exome
AF:
0.670
Gnomad EAS exome
AF:
0.930
Gnomad SAS exome
AF:
0.612
Gnomad FIN exome
AF:
0.572
Gnomad NFE exome
AF:
0.582
Gnomad OTH exome
AF:
0.621
GnomAD4 exome
AF:
0.589
AC:
832319
AN:
1413542
Hom.:
250445
Cov.:
27
AF XY:
0.590
AC XY:
415494
AN XY:
704166
show subpopulations
Gnomad4 AFR exome
AF:
0.291
Gnomad4 AMR exome
AF:
0.697
Gnomad4 ASJ exome
AF:
0.663
Gnomad4 EAS exome
AF:
0.937
Gnomad4 SAS exome
AF:
0.612
Gnomad4 FIN exome
AF:
0.573
Gnomad4 NFE exome
AF:
0.577
Gnomad4 OTH exome
AF:
0.603
GnomAD4 genome
AF:
0.523
AC:
79610
AN:
152076
Hom.:
22631
Cov.:
33
AF XY:
0.531
AC XY:
39499
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.298
Gnomad4 AMR
AF:
0.635
Gnomad4 ASJ
AF:
0.644
Gnomad4 EAS
AF:
0.932
Gnomad4 SAS
AF:
0.620
Gnomad4 FIN
AF:
0.580
Gnomad4 NFE
AF:
0.581
Gnomad4 OTH
AF:
0.568
Alfa
AF:
0.586
Hom.:
66336
Bravo
AF:
0.522
TwinsUK
AF:
0.575
AC:
2131
ALSPAC
AF:
0.590
AC:
2272
ESP6500AA
AF:
0.297
AC:
1307
ESP6500EA
AF:
0.591
AC:
5074
ExAC
AF:
0.592
AC:
71626
Asia WGS
AF:
0.707
AC:
2459
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 26, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 26662070, 22882535, 24792890, 22356187) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hypergonadotropic hypogonadism Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Leydig cell agenesis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Gonadotropin-independent familial sexual precocity Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
12
DANN
Benign
0.93
DEOGEN2
Benign
0.078
T;.;.
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.43
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.62
T;T;T
MetaRNN
Benign
9.4e-7
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.73
N;.;.
PrimateAI
Benign
0.33
T
PROVEAN
Benign
0.080
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.72
T;T;T
Sift4G
Benign
0.77
T;T;T
Polyphen
0.0040
B;.;.
Vest4
0.067
MPC
0.068
ClinPred
0.0051
T
GERP RS
3.9
Varity_R
0.043
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.35
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.35
Position offset: -12

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2293275; hg19: chr2-48921375; COSMIC: COSV54295902; API